Share this article

print logo

Unyts to offer hospitals blood donations with pathogen-reduced platelets

Unyts, the regional organ, eye and tissue center, now is also one of the first in the nation to offer hospitals blood donations with pathogen-reduced platelets in 100 percent plasma following approval by the Food and Drug Administration, the organization announced.

The organization will use the Cerus Corp.’s Intercept blood system to reduce the risk of transfusion-transmitted infections by inactivating a range of pathogens, such as viruses and bacteria, that may be present in donated blood. The system’s nucleic acid targeting mechanism of action is designed to inactivate established transfusion threats, including hepatitis B and C, HIV, and West Nile virus, as well as such emerging pathogens as malaria and dengue.

Initial rollout involves Buffalo General Medical Center, with pathogen-reduced platelets becoming more widely used across the region as availability increases, the organization reported.

There are no comments - be the first to comment